WallStreetZenWallStreetZen

NASDAQ: NBTX
Nanobiotix Sa Stock

$6.30-0.05 (-0.79%)
Updated Feb 21, 2024
NBTX Price
$6.30
Fair Value Price
-$2.10
Market Cap
$221.95M
52 Week Low
$1.75
52 Week High
$11.00
P/E
-3.53x
P/B
-3.88x
P/S
23.87x
PEG
N/A
Dividend Yield
N/A
Revenue
$7.17M
Earnings
-$64.60M
Gross Margin
100%
Operating Margin
-657.39%
Profit Margin
-872.2%
Debt to Equity
-1.75
Operating Cash Flow
-$41M
Beta
1.06
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NBTX Overview

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NBTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NBTX ($6.30) is overvalued by 399.95% relative to our estimate of its Fair Value price of -$2.10 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
NBTX ($6.30) is not significantly undervalued (399.95%) relative to our estimate of its Fair Value price of -$2.10 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
NBTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NBTX due diligence checks available for Premium users.

Be the first to know about important NBTX news, forecast changes, insider trades & much more!

NBTX News

Valuation

NBTX fair value

Fair Value of NBTX stock based on Discounted Cash Flow (DCF)
Price
$6.30
Fair Value
-$2.10
Undervalued by
399.95%
NBTX ($6.30) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NBTX ($6.30) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NBTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NBTX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.53x
Industry
16.04x
Market
28.8x

NBTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-3.88x
Industry
5.97x

NBTX's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
NBTX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NBTX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$44.4M
Liabilities
$103.5M
Debt to equity
-1.75
NBTX's short-term liabilities ($53.04M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NBTX's long-term liabilities ($47.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NBTX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NBTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
NBTX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NBTX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NBTX$221.95M-0.79%-3.53x-3.88x
QSI$223.93M-1.25%-2.08x0.77x
SGMO$219.02M+4.66%-0.86x1.62x
INMB$226.89M-6.74%-8.28x5.16x
CMPX$229.48M-2.70%-5.45x1.43x

Nanobiotix Sa Stock FAQ

What is Nanobiotix Sa's quote symbol?

(NASDAQ: NBTX) Nanobiotix Sa trades on the NASDAQ under the ticker symbol NBTX. Nanobiotix Sa stock quotes can also be displayed as NASDAQ: NBTX.

If you're new to stock investing, here's how to buy Nanobiotix Sa stock.

What is the 52 week high and low for Nanobiotix Sa (NASDAQ: NBTX)?

(NASDAQ: NBTX) Nanobiotix Sa's 52-week high was $11.00, and its 52-week low was $1.75. It is currently -42.73% from its 52-week high and 260% from its 52-week low.

How much is Nanobiotix Sa stock worth today?

(NASDAQ: NBTX) Nanobiotix Sa currently has 35,230,382 outstanding shares. With Nanobiotix Sa stock trading at $6.30 per share, the total value of Nanobiotix Sa stock (market capitalization) is $221.95M.

Nanobiotix Sa stock was originally listed at a price of $15.95 in Dec 14, 2020. If you had invested in Nanobiotix Sa stock at $15.95, your return over the last 3 years would have been -60.5%, for an annualized return of -26.63% (not including any dividends or dividend reinvestments).

How much is Nanobiotix Sa's stock price per share?

(NASDAQ: NBTX) Nanobiotix Sa stock price per share is $6.30 today (as of Feb 21, 2024).

What is Nanobiotix Sa's Market Cap?

(NASDAQ: NBTX) Nanobiotix Sa's market cap is $221.95M, as of Feb 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nanobiotix Sa's market cap is calculated by multiplying NBTX's current stock price of $6.30 by NBTX's total outstanding shares of 35,230,382.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.